Anthony Rodriguez

Anthony Rodriguez is a PhD candidate in bioengineering at the the University of Washington, and the president emeritus of the Student Engineering Business Association at UW. He is also co-founder of nPostBio.

Recent posts

No Time for the Academic Entrepreneur
The recurring question I hear from so many people in business is: “Why aren’t more startups generated by the university system?” It’s not an easy question, certainly not one to be... Read more »
It Takes a Village to Raise an Entrepreneur: Cultivating the Emerging Seattle Talent Pool
It can be argued that among talent, cash and technology, no factor is more critical to a start up than talent. The talent drives innovation, attracts the venture capital and makes... Read more »
UW Business Plan Competition Kick-Starts Companies to Action
The University of Washington Business Plan Competition hosted by the Center for Innovation and Entrepreneurship (CIE) came to a close Thursday night, handing out $60,000 in prize money to an impressive... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Video
The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace

Sponsored · Whitepaper
Bridging the Diversity Gap with Decentralized Trials
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
PRA Health Sciences

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4

FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats

Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

“Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Anthony Rodriguez

Recent posts

No Time for the Academic Entrepreneur

It Takes a Village to Raise an Entrepreneur: Cultivating the Emerging Seattle Talent Pool

UW Business Plan Competition Kick-Starts Companies to Action

Underwriters and Partners

The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development

Bridging the Diversity Gap with Decentralized Trials

The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

Xconomy on Demand

We offer a number of ways to subscribe for free!